NCBiotech News

Grifols, a global biotherapeutics company with major operations in North Carolina, announced today that it will begin production of a plasma-derived treatment to battle the Ebola virus for the country of Liberia at its flagship Clayton manufacturing site.

AveXis, an Illinois-based clinical-stage company developing gene therapies for neurological genetic diseases, is investing $55 million in a new Durham manufacturing facility that will create 200 jobs. 

Grifols, already the largest private employer in Johnston County, is about to get even bigger.

North Carolina’s reputation as “Vaccine Central” has enjoyed an official boost from federal regulators, thanks to marketing approval for Novartis’ flu vaccine using the highly efficient process of cell culture.

bioMASON is adding a new brick-and-mortar headquarters to its Research Triangle Park brick-and-mortar biotech business.

An ancient relative of tobacco is at the heart of a new COVID-19 vaccine under development by Medicago and GSK.

A Durham startup, BIOMILQ, has a mission to replicate the nutritional profile of breastmilk with mammary cells outside the body.

Grifols, a global biotherapeutics company with major operations in North Carolina, has begun producing the first specific COVID-19 drug at its manufacturing campus in Clayton.

Grifols, a global biotherapeutics company with more than 2,000 employees in North Carolina, is adding 300 more to its Clayton workforce as part of a $351.6 million expansion there.

A grant to help train military service members in North Carolina and Texas for biopharmaceutical manufacturing careers has been approved by the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL).

People at North Carolina’s huge military bases who are transitioning into civilian life are getting an amazing new opportunity, thanks to NCBiotech and its partners. 

North Carolina’s global gene therapy leadership was boosted today with the announcement that AveXis, Inc., is doubling its planned workforce and investing $60 million more in its new Durham County manufacturing facility.

KriGen Pharmaceuticals, a young India-based pharmaceutical company, is investing $7 million and hiring 100 employees at its new manufacturing facility and quality control lab in the Harnett County community of Lillington, about 30 miles south of Raleigh.

Grifols is collecting a blood product from recovered COVID-19 patients to develop a possible treatment for the coronavirus disease.

Banner Life Sciences, a High Point pharmaceutical company, has gained final regulatory approval of a drug for treating multiple sclerosis.